Evidence map›Paper›PMID 38044289›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Targeting YAP1-regulated Glycolysis in Fibroblast-Like Synoviocytes Impairs Macrophage Infiltration to Ameliorate Diabetic Osteoarthritis Progression.

Jie Yang, Shanshan Li, Zhenyan Li, Lutian Yao, Meijing Liu, Kui-Leung Tong, Qiutong Xu, Bo Yu, Rui Peng, Tao Gui and 9 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Lipopolysaccharide promotes rheumatoid arthritis by enhancing Wnt7b mediated macrophage-FLS communication.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Application and prospects of nanomaterials in osteoporosis treatment.International journal of pharmaceutics: X · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Jie YangDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Shanshan LiState Key Laboratory of Pulp and Paper Engineering, South China University of Technology, Guangzhou, 510640, China.
Zhenyan LiDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Lutian YaoDepartment of Orthopedics, The First Hospital of China Medical University, Shenyang, 110001, China.
Meijing LiuKey Laboratory of Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Kui-Leung TongDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Qiutong XuDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Bo YuDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Rui PengDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Tao GuiDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Wang TangDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Yidi XuDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Jiaxu ChenGuangzhou Key Laboratory of Formula-Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, 510640, China.
Jun HeInstitute of Laboratory Animal Science, Jinan University, Guangzhou, 510632, China.
Kewei ZhaoGuangzhou Key Laboratory of Chinese Medicine Research on Prevention and Treatment of Osteoporosis, the Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510375, China.
Xiaogang WangKey Laboratory of Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, 100191, China.
Xiaoying WangState Key Laboratory of Pulp and Paper Engineering, South China University of Technology, Guangzhou, 510640, China.ORCID 0000-0002-9303-6509
Zhengang ZhaDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.
Huan-Tian ZhangDepartment of Bone and Joint Surgery, the First Affiliated Hospital of Jinan University, Key Laboratory of Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, 510630, China.ORCID 0000-0002-7391-436X
First Affiliated Hospital of Jinan University · CNGuangzhou University of Chinese Medicine · CNStomatology Hospital · CNFirst Hospital of China Medical University · CNJinan University · CNSouth China University of Technology · CN

Funding

Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University, China JNU1AF-CFTP-2022-a01221Guangdong Basic and Applied Basic Research Foundation 2017A030313556Guangdong Basic and Applied Basic Research Foundation 2017A030313665Guangdong Basic and Applied Basic Research Foundation 2019A1515011082Guangdong Basic and Applied Basic Research Foundation 2021A1515012154Guangdong Basic and Applied Basic Research Foundation 2022A1515111048Guangdong Basic and Applied Basic Research Foundation 2023B1515020007Key Laboratory Construction Project of Guangzhou Science and Technology Bureau 202102100007National Key Research and Development Program of China 2021YFA1102600National Natural Science Foundation of China 81602360National Natural Science Foundation of China 81672224National Natural Science Foundation of China 81871809National Natural Science Foundation of China 82072470National Natural Science Foundation of China 82103781National Natural Science Foundation of China 82350003National Natural Science Foundation of China 92049201
6 · The paper itself

Abstract

The interplay between immune cells/macrophages and fibroblast-like synoviocytes (FLSs) plays a pivotal role in initiating synovitis; however, their involvement in metabolic disorders, including diabetic osteoarthritis (DOA), is largely unknown. In this study, single-cell RNA sequencing (scRNA-seq) is employed to investigate the synovial cell composition of DOA. A significant enrichment of activated macrophages within eight distinct synovial cell clusters is found in DOA synovium. Moreover, it is demonstrated that increased glycolysis in FLSs is a key driver for DOA patients' synovial macrophage infiltration and polarization. In addition, the yes-associated protein 1 (YAP1)/thioredoxin-interacting protein (TXNIP) signaling axis is demonstrated to play a crucial role in regulating glucose transporter 1 (GLUT1)-dependent glycolysis in FLSs, thereby controlling the expression of a series of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) which may subsequently fine-tune the infiltration of M1-polarized synovial macrophages in DOA patients and db/db diabetic OA mice. For treatment, M1 macrophage membrane-camouflaged Verteporfin (Vt)-loaded PLGA nanoparticles (MVPs) are developed to ameliorate DOA progression by regulating the YAP1/TXNIP signaling axis, thus suppressing the synovial glycolysis and the infiltration of M1-polarized macrophages. The results provide several novel insights into the pathogenesis of DOA and offer a promising treatment approach for DOA.

Indexed as

Diabetes MellitusOsteoarthritisSynoviocytesAdaptor Proteins, Signal TransducingAnimalsFibroblastsGlycolysisHumansMacrophagesMiceTranscription FactorsAdaptor Proteins, Signal TransducingTranscription Factorsdiabetic osteoarthritisfibroblast-like synoviocytesglycolysismacrophages infiltrationYAP1

Identifiers

PMID38044289
PMCPMC10837355
OpenAlexW4389291071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.